Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/05/2008 | US20080131379 Brush-like properties; whitening agent, fresh-breath agent, anti-plaque agent, anti-gingivitis agent, and re-mineralization agent |
06/05/2008 | US20080131377 Pharmaceutical Aerosol Compositions |
06/05/2008 | US20080131372 Extruding mixture of alpha-2 adrenergic receptor agonist (brimonidine) and biodegradable polylactide |
06/05/2008 | US20080131369 Compositions And Methods For Enhancing Contrast In Imaging |
06/05/2008 | US20080131366 Administering folate receptor alpha inducer comprising steroid receptor agent optionally with one or more histone deacetylase inhibitors to treat or diagnose a patient having a solid tumor; increases levels of receptors on cancer cell plasma membranes and in serum, ascites and cerebrospinal fluid |
06/05/2008 | US20080127972 Dry Powder Inhaler Formulations Comprising Surface-Modified Particles With Anti-Adherent Additives |
06/05/2008 | DE202006020222U1 Schnell zerfallende Darreichungsform umfassend Magnesiumcarbonat schwer Rapidly disintegrating dosage form comprising magnesium difficult |
06/05/2008 | DE202005021512U1 Macrogol-Präparat Macrogol preparation |
06/05/2008 | DE102006056697A1 Galanthamin-haltiges Arzneimittel mit kontrollierter Freisetzung Galanthamine-containing pharmaceutical controlled release |
06/05/2008 | CA2677750A1 Transdermal delivery systems |
06/05/2008 | CA2671462A1 Film-coated solid dosage form |
06/05/2008 | CA2671094A1 Oxygen supply for cell transplant and vascularization |
06/05/2008 | CA2671092A1 Divisible osmotic dosage forms and methods of use |
06/05/2008 | CA2671081A1 Stabilized adhesive preparation containing donepezil |
06/05/2008 | CA2671006A1 Method for suppressing discoloration over time of adhesive preparation containing donepezil |
06/05/2008 | CA2671001A1 Pharmaceutical composition of memantine |
06/05/2008 | CA2671000A1 Method for suppressing coloring of adhesive preparation containing donepezil and method for reducing amounts of donepezil-related substances formed |
06/05/2008 | CA2670995A1 Stabilized adhesive preparation containing donepezil |
06/05/2008 | CA2670991A1 Percutaneously absorbable preparation comprising donepezil |
06/05/2008 | CA2670971A1 Adhesive skin patch and method for evaluation of adhesive skin patch |
06/05/2008 | CA2670683A1 Decontaminant edible product, methods of production and uses thereof |
06/05/2008 | CA2670601A1 Ointment compositions comprising a vitamin d derivative |
06/05/2008 | CA2670599A1 Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use |
06/05/2008 | CA2670578A1 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof |
06/05/2008 | CA2670552A1 Novel compositions |
06/05/2008 | CA2670544A1 Estrogen/ serm and estrogen/ progestin bi-layer tablets |
06/05/2008 | CA2670517A1 Medicament with controlled release containing galanthamine |
06/05/2008 | CA2670440A1 Use of beta-lactamase |
06/05/2008 | CA2669938A1 Solid pharmaceutical dosage formulations |
06/05/2008 | CA2669815A1 Nanoparticulate formulations and methods for the making and use thereof |
06/05/2008 | CA2668814A1 Water insoluble polymer matrix for drug delivery |
06/05/2008 | CA2668124A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
06/05/2008 | CA2666564A1 Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue |
06/05/2008 | CA2665226A1 Novel formulations of proton pump inhibitors and methods of using these formulations |
06/05/2008 | CA2664400A1 Particles for cell targeting |
06/04/2008 | EP1927397A1 Absorbent composition for surface treatment |
06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
06/04/2008 | EP1927366A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (RSV) |
06/04/2008 | EP1927358A1 Sustained-release preparation |
06/04/2008 | EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof |
06/04/2008 | EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof |
06/04/2008 | EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof |
06/04/2008 | EP1927354A1 Novel substituted benzimidazole dosage forms and method of using same |
06/04/2008 | EP1927353A1 Remedy for corneal diseases |
06/04/2008 | EP1927347A1 Bitterness-reducing agent |
06/04/2008 | EP1927336A2 Inverse autoinversible latices based on fatty acid esters and cosmetic, dermocosmetic, dermopharmaceutic or pharmaceutic compositions |
06/04/2008 | EP1926521A2 Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
06/04/2008 | EP1926505A1 In vivo formed matrices including natural biodegradable polysaccharides and ophthalmic uses thereof |
06/04/2008 | EP1926489A2 Liposomes for treatment of multiple myeloma |
06/04/2008 | EP1926482A2 Pharmaceutical form with sustained ph-independent active ingredient release for active ingredients having strong ph-dependent solubility |
06/04/2008 | EP1926481A2 Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses |
06/04/2008 | EP1926480A2 Method for the production of soft capsule envelopes based on polyvinyl alcohol-polyethylene glycol graft polymers |
06/04/2008 | EP1926479A2 Drug compositions containing controlled release hypromellose matrices |
06/04/2008 | EP1926478A2 Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof |
06/04/2008 | EP1926477A1 Composition comprising a nsaid and paracetamol |
06/04/2008 | EP1926476A2 Amorphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide |
06/04/2008 | EP1926475A1 Oral vehicle for systemic pharmaceuticals |
06/04/2008 | EP1926474A1 Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability |
06/04/2008 | EP1926473A2 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes |
06/04/2008 | EP1926472A2 Stabilized and preserved ketotifen ophthalmic compositions |
06/04/2008 | EP1817013B1 Enteric coated bead comprising ixabepilone |
06/04/2008 | EP1565229A4 Apparatus and methods for activating a delivery device |
06/04/2008 | EP1478339B1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
06/04/2008 | EP1474119B1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
06/04/2008 | EP1377316B1 Pharmaceutical composition based on azalides for topical application in ophthalmology |
06/04/2008 | EP1189614B1 Solid preparations containing paroxetine |
06/04/2008 | EP1146959B1 Apparatus for liposome production |
06/04/2008 | EP1008354B1 Immediately disintegrable medicinal compositions |
06/04/2008 | CN201067526Y Multifunctional plaster |
06/04/2008 | CN201067525Y Medical plaster |
06/04/2008 | CN101193962A Amine polymer-modified nanoparticulate carriers |
06/04/2008 | CN101193657A Endoparasiticide |
06/04/2008 | CN101193640A Pharmaceutical compositions of a neuroactive steroid and uses thereof |
06/04/2008 | CN101193639A Tanaproget compositions containing ethinyl estradiol |
06/04/2008 | CN101193638A Therapeutic combination in case of benign prostate hyperplasia |
06/04/2008 | CN101193634A Roflumilast eye drop |
06/04/2008 | CN101193629A A topical composition and its uses |
06/04/2008 | CN101193627A Use of a partially neutralized, anionic (meth) acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values |
06/04/2008 | CN101193626A Controlled release formulations of octreotide |
06/04/2008 | CN101193625A Sugar-coated tablet |
06/04/2008 | CN101193624A Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying |
06/04/2008 | CN101193623A Reticulated elastomeric matrices manufacture and use |
06/04/2008 | CN101193622A Method and composition for treating inflammatory disorders |
06/04/2008 | CN101190890A 5-[(2R)-[2-[2-[2-(2,2,2-trifluoroethoxyl)phenoxyl]ethyl]amino]propyl]-2-methoxylbenzsulfamide |
06/04/2008 | CN101190332A Vibrio anguilarum oil oral-emulsified bivalent vaccine and preparation thereof |
06/04/2008 | CN101190328A Day coriander traditional Chinese medicine spray agent |
06/04/2008 | CN101190327A í«Kanlijiaobuyeí» a kind of traditional Chinese medicinal oral liquid |
06/04/2008 | CN101190326A Notoginseng keshi granule |
06/04/2008 | CN101190324A Externally-used tincture for treating hepatitis B |
06/04/2008 | CN101190321A Proprietary Chinese medicine preparations for treating uric acid nephropathy and preparation method thereof |
06/04/2008 | CN101190320A Traditional Chinese medicine granules for treating psoriasis |
06/04/2008 | CN101190319A Traditional Chinese medicine for treating diabetes |
06/04/2008 | CN101190318A Traditional Chinese medicine for treating I-type and II-type diabetes |
06/04/2008 | CN101190317A Compound carapax trionycis capsule for expelling toxin, softening liver and becoming yin |
06/04/2008 | CN101190316A Traditional Chinese medicine composition for treating infantile malnutrition |
06/04/2008 | CN101190315A Traditional Chinese medicine composition for treating melancholia and preparation method thereof |
06/04/2008 | CN101190314A Traditional Chinese medicine formula for treating acute or chronic gastritis and preparation method |
06/04/2008 | CN101190309A Traditional Chinese medicine for treating perimenopause syndrome |
06/04/2008 | CN101190308A Ginseng deer kidney-invigorating traditional Chinese medicine preparation and preparation method thereof |
06/04/2008 | CN101190307A Traditional Chinese medicine compound preparations for treating congestive heart failure |